Invention Grant
- Patent Title: Use of amisulpride as an anti-emetic
-
Application No.: US16105268Application Date: 2018-08-20
-
Publication No.: US10525033B2Publication Date: 2020-01-07
- Inventor: Julian Clive Gilbert , Robert William Gristwood , Nicola Cooper , Gabriel Fox
- Applicant: Acacia Pharma Limited
- Applicant Address: GB Duxford, Cambridge
- Assignee: Acacia Pharma Limited
- Current Assignee: Acacia Pharma Limited
- Current Assignee Address: GB Duxford, Cambridge
- Agency: Cooley LLP
- Agent Heidi A. Erlacher; Chen Chen
- Priority: GB1004020.2 20100311
- Main IPC: A61K31/40
- IPC: A61K31/40 ; A61K9/00 ; A61K47/12 ; A61K31/282 ; A61K31/4178 ; A61K31/485 ; A61K45/06 ; A61K33/24 ; A61K31/573
Abstract:
Amisulpride is used in the therapy of nausea, vomiting or retches. The therapy may utilize a novel injectable formulation, in unit dosage form, comprising less than 50 mg amisulpride.
Public/Granted literature
- US20180353473A1 USE OF AMISULPRIDE AS AN ANTI-EMETIC Public/Granted day:2018-12-13
Information query
